
Please use this identifier to cite or link to this item:
http://172.20.40.131:8080/jspui/handle/123456789/566
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kansara, B. | - |
dc.contributor.author | Pandya, H. | - |
dc.contributor.author | Shah, D. | - |
dc.contributor.author | Vadhavania, S. | - |
dc.date.accessioned | 2019-08-08T10:02:30Z | - |
dc.date.available | 2019-08-08T10:02:30Z | - |
dc.date.issued | 2016-10 | - |
dc.identifier.issn | 2321-9327 | - |
dc.identifier.uri | http://localhost:80/xmlui/handle/123456789/566 | - |
dc.description.abstract | Introduction: Mixed connective tissue disorder (MCTD), unlike other connective tissue disorders have a milder course. MTCD with only digital gangrene without organ damage, as an initial presentation is rare. Case Report : A young female presented with c/o fever and blackish discoloration of all toes and fingers (toes > fingers). All her major organ functions were normal. Her CRP was raised and U1 snRNP antibody was positive. She responded well to injectable steroids. Conclusion: This patient with presentation of diffuse digital gangrene was diagnosed with MTCD, without major organ involvement and showed good recovery with steroids. So MCTD is a reversible cause of digital gangrene and should be considered in young females without risk factors of developing gangrene. | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | International Journal of Current Medical And Applied Sciences | en_US |
dc.subject | Digital Gangrene | en_US |
dc.subject | MCTD | en_US |
dc.subject | U1 Snrnp Antibody | en_US |
dc.subject | Steroids | en_US |
dc.title | Acute Diffuse Digital Gangrene- A Rare Initial Manifestation of Mixed Connective Tissue Disorder (MCTD). | en_US |
dc.type | Article | en_US |
Appears in Collections: | Faculty Publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
IJCMAAS_OCT_2016_VOL12_ISS2_04.pdf | 392.95 kB | Adobe PDF | ![]() View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.